Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H S Parra

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
Soft tissue and bone sarcomasA Santoro, H S Parra
Tumori|January 5, 2002
Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagusP Bidoli, S C Stani, D De Candis, et al.
British Journal of Cancer|June 10, 2004
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancerH S Parra, R Cavina, F Latteri, et al.
Seminars in Oncology|February 1, 1995
A summary of the Milan experience with multimodality therapies in patients with small cell lung cancer: attempts to improve long-term outcomeA Santoro, H S Parra, P Bidoli, et al.
Poultry Science|February 25, 2016
Molecular detection of chicken parvovirus in broilers with enteric disorders presenting curving of duodenal loop, pancreatic atrophy, and mesenteritisL F N Nuñez, L R M Sá, S H S Parra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II studyA Santoro, H Bredenfeld, L Devizzi, et al.
Cancer|August 16, 2001
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)H S Parra, L Tixi, F Latteri, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
Soft tissue and bone sarcomasA Santoro, H S Parra
Tumori|January 5, 2002
Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagusP Bidoli, S C Stani, D De Candis, et al.
British Journal of Cancer|June 10, 2004
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancerH S Parra, R Cavina, F Latteri, et al.
Seminars in Oncology|February 1, 1995
A summary of the Milan experience with multimodality therapies in patients with small cell lung cancer: attempts to improve long-term outcomeA Santoro, H S Parra, P Bidoli, et al.
Poultry Science|February 25, 2016
Molecular detection of chicken parvovirus in broilers with enteric disorders presenting curving of duodenal loop, pancreatic atrophy, and mesenteritisL F N Nuñez, L R M Sá, S H S Parra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II studyA Santoro, H Bredenfeld, L Devizzi, et al.
Cancer|August 16, 2001
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)H S Parra, L Tixi, F Latteri, et al.
Pageof 1